- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/345 - Nitrofurans
Patent holdings for IPC class A61K 31/345
Total number of patents in this class: 78
10-year publication summary
|
5
|
2
|
7
|
4
|
2
|
9
|
3
|
8
|
8
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DSM IP Assets B.V. | 5581 |
3 |
| Bharat Biotech International Limited | 89 |
3 |
| Centre National de La Recherche Scientifique | 10516 |
2 |
| The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | 112 |
2 |
| The Penn State Research Foundation | 1542 |
2 |
| University of Utah Research Foundation | 1820 |
2 |
| Nanjing Shijiang Medicine Technology Co., Ltd | 27 |
2 |
| The Regents of the University of California | 20059 |
1 |
| AstraZeneca AB | 2908 |
1 |
| AstraZeneca UK Limited | 633 |
1 |
| Boehringer Ingelheim International GmbH | 4642 |
1 |
| The Johns Hopkins University | 5709 |
1 |
| President and Fellows of Harvard College | 5995 |
1 |
| Academisch Ziekenhuis Groningen | 118 |
1 |
| Acies Bio d.o.o. | 35 |
1 |
| Akebia Therapeutics, Inc. | 114 |
1 |
| Akita University | 98 |
1 |
| Aragon Pharmaceuticals, Inc. | 71 |
1 |
| Association Francaise Contre Les Myopathies (afm) | 10 |
1 |
| British Columbia Cancer Agency Branch | 192 |
1 |
| Other owners | 49 |